OBJECTIVES: Previous studies demonstrated that preconditioning with argon gas provided a marked reduction in inflammation and apoptosis and increased myocardial contractility in the setting of acute myocardial ischaemia-reperfusion (IR). There is substantial evidence that myocardial IR injury following cardioplegic arrest is associated with the enhancement of apoptosis and inflammation, which is considered to play a role in cardiac functional impairment. Therefore, the present study was designed to clarify whether preconditioning with argon gas enhances recovery of cardiac function following cardioplegic arrest.
INTRODUCTION
Myocardial protection during cardiac surgery has been the focus of both clinical and experimental research for the last 5 decades, but the debate regarding the ultimate cardioprotective strategies is ongoing. An effective cardioprotection during limited periods of global ischaemia (1-2 h), e.g. in patients who have open-heart surgery (coronary artery bypass surgery, valve replacement) can be achieved by using different types of cardioplegic solutions [1] . However, effective, powerful clinical reperfusion strategies are lacking. Previous experimental and clinical researchers have extensively studied how to reduce ischaemia-reperfusion (IR) injury during cardiac surgery, but only a few have provided suggestions for sufficient and superior cardioprotective effects. One of the most promising approaches, first described by Murry et al. [2] , showed that short periods of coronary artery occlusion substantially reduced myocardial infarct size. This phenomenon is called 'ischaemic preconditioning'. This form of adaptation to ischaemic stress has been confirmed in many subsequent studies and provides an enhanced recovery of myocardial contractile function following reperfusion [3] . Moreover, remote ischaemic preconditioning (transient IR of the arm or other remote organ and tissue) significantly reduced perioperative myocardial injury and improved short-term clinical outcome in patients undergoing cardiac bypass surgery [4] . However, a recent large clinical trial provided conflicting results and failed to demonstrate the beneficial effect of remote ischaemic preconditioning in patients undergoing cardiac surgery [5] .
Cardioprotection from either noble gases or volatile anaesthetics share similarities in signalling pathways and are involved in the cardioprotective effect of preconditioning [6] . In this context, the noble (inert) gases xenon, argon and helium have been shown to provide organ-protective effects [7] . Natural air is 0.94% argon; therefore, its purification costs are far lower. Furthermore, whereas xenon is an anaesthetic gas under normobaric conditions, argon only exerts anaesthetic effects under hyperbaric conditions, thereby allowing its application even in conscious patients. Although there is no evidence of direct toxic effects of argon, 2 recent studies demonstrated adverse effects of argon in an experimental model of middle cerebral artery occlusion [8, 9] . This is in contrast to Ryang et al. [10] , who demonstrated the neuroprotective effects of argon in the same experimental model. Most importantly, there are no data on adverse effects of argon in the setting of myocardial IR. In contrast, recent studies have shown that argon (30-80%) pre-or postconditioning markedly reduced infarct size and improved postischaemic cardiac function in a setting of acute myocardial infarction [11, 12] . In addition, we also recently published a study in which preconditioning with argon (30% and 50%) significantly reduced apoptosis and inflammation and enhanced the survival of human adult cardiomyocytes exposed to hypoxia [13] . Collectively, these data suggest that preconditioning with argon might have a therapeutic potential for limiting perioperative myocardial injury. Therefore, our goal was to clarify whether preconditioning with argon gas enhances recovery of cardiac function in rat hearts arrested with histidine-tryptophan-ketoglutarate (HTK) cardioplegia.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats (12-15 weeks old, Department for Laboratory Animal Science and Genetics, Himberg, Austria) were used in the study. The experimental protocol was approved by the regional ethics committee for laboratory animal experiments at the Experimental protocol: haemodynamic evaluation in the isolated heart model The experimental protocol is illustrated in Fig. 1 . In total, 30 adult male Sprague-Dawley rats were anaesthetized by intraperitoneal administration of xylazine (4 mg/kg; Bayer, Germany) and ketamine (100 mg/kg; Dr E. Gräub AG, Switzerland). Rats were allocated to (i) controls (control IR group, n = 10) and (ii) 3 cycles of argon [50% argon, 21% oxygen (O 2 ) and 29% nitrogen (N 2 ), n = 10; argon IR group] administered for 5 min interspersed with 5 min of (79% N 2 and 21% O 2 ) before their hearts were harvested. Then, the rats were given heparin (200 IU intravenously), and their hearts were rapidly excised from the thorax, immersed in ice-cold Krebs-Henseleit buffer and mounted on an erythrocyte-perfused, isolated working heart system (Hugo Sachs Elektronik, Freiburg, Germany) as described previously [14] . The perfusate consisted of a Krebs-Henseleit buffer-based suspension of purified bovine erythrocytes (haematocrit 30%). Oxygenation was performed with a gas mixture [75% N 2 , 20% O 2 , 5% carbon dioxide (CO 2 )] to provide a constant partial pressure of O 2 of 100 ± 10 mmHg. Composition of the buffer was as follows (in mmol/l): sodium chloride, 118; potassium chloride, 4.7; calcium chloride, 2.5; magnesium sulphate, 1.2; monopotassium phosphate, 1.2; disodium ethylenediaminetetraacetate, 0.5; sodium bicarbonate, 25; glucose: 11.1; insulin, 2.5 IU/l and bovine albumin, 2 g/l. During the stabilzation period, the hearts were in the Langendorff mode (LD) with constant-pressure coronary perfusion at 70 mmHg. After 15 min of stabilizing in the LD, the left atrium was cannulated via a pulmonary vein and anterograde perfusion of the left atrium and left ventricle was begun; the heart was ejected against a defined afterload of 70 mmHg for 20 min (working heart mode). Then, the heart (control IR and argon IR) was arrested by HTK crystalloid cardioplegia (single anterograde application; Custodiol V R ; 2.48 ml/g heart weight; Dr. Franz Köhler Chemie GmbH, Germany) and subjected to 60 min of global cold ischaemia (37 C), followed by reperfusion for 40 min. In addition, coronary effluent was collected for 1 min ('snapshot') at the following times: 10 min prior to cardiac arrest and during reperfusion at 10 min to assess lactate dehydrogenase (LDH, expressed as mU/ml) levels as a marker of myocardial IR injury. Arterial and coronary venous blood perfusates were taken (prior to cardiac arrest and at 20 min of reperfusion) to monitor adequate oxygenation.
In addition, 4 rats were anaesthetised, and the hearts were mounted onto an isolated working heart system but were not subjected to either cardiac arrest or to argon preconditioning (sham control). These hearts were used as the sham control to provide sufficient evidence about cardiac damage and metabolic alterations due to myocardial IR.
Four of 30 rats had massive bleeding during the carotid artery cannulation (2 rats in the control IR group, 2 rats in argon IR group); 2 additional hearts were excluded because of the large expanse of haemorrhage on the left ventricle (1 heart in the control IR group and 1 heart in the argon IR group).
Ex vivo haemodynamic data acquisition
Haemodynamic data were assessed as described previously [14, 15] . Detailed information is shown in the Supplementary Material, Section 1.
Western blot
Detailed information is shown in the Supplementary Material, Section 2.
Biochemical evaluation
Detailed information is shown in the Supplementary Material, Section 3.
Statistical analysis
Data are presented as mean ± standard deviation. Baseline haemodynamic data, high-energy phosphates and energy charges for all groups were compared using one-way analysis of variance. Subsequently, Bonferroni's post hoc test was used. Repeated-measures analysis of variance with Sidak's multiple comparisons test was used to compare cardiac functional recovery data between groups at 15 min, 20 min, 30 min and 40 min following reperfusion. The unpaired t-test was used to compare the 2 groups. A P-value <0.05 was considered significant. Analysis was performed using Prism TM 6 software (GraphPad Inc., San Diego, CA, USA).
RESULTS
The effect of argon preconditioning on postischaemic cardiac function Table 1 presents animal characteristics and baseline haemodynamic values. No significant differences were noted in the haemodynamic parameters between the groups. In addition, no differences were noted in baseline levels of LDH in the coronary effluent between the control IR and the argon IR groups (26.2 ± 2.3 mU/ml vs 24.7 ± 2.7 mU/ml) prior to cardiac arrest. However, the concentration of LDH from the coronary effluent was markedly attenuated during reperfusion at 10 min in the argon IR group in comparison with the control IR group (35.8 ± 2.5 mU/ml vs 49.6 ± 2.3 mU/ml, P = 0.004; n = 6 from both groups). Haemodynamic recovery during reperfusion was presented as percent recovery at 15 min, 20 min, 30 min and 40 min (Fig. 2) . Cardiac functional parameters at 40 min of reperfusion were markedly enhanced in rat hearts that were preconditioned with argon following HTK cardioplegia arrest; cardiac output (101 ± 6% vs 87 ± 11%; P = 0.003; Fig. 2A) ; stroke volume (94 ± 4% vs 80 ± 11%, P = 0.001; Fig. 2B ), external heart work (100 ± 6% vs 81 ± 13%; P = 0.005; Fig. 2C ) and left ventricular (LV) systolic pressure (94 ± 4% vs 99 ± 1%, P = 0.009 Fig. 2D ). In addition, coronary flow was remarkably enhanced in the group preconditioned with argon in comparison to the control IR group at 40 min of reperfusion (90 ± 13% vs 125 ± 21%; P < 0.001 vs control IR; Fig. 2E ). The change in heart rate following reperfusion was comparable between groups (Fig. 2F ).
The effect of argon preconditioning on ERK1/2, Akt and eNOS activation following global cold ischaemia and subsequent reperfusion
The effects of argon preconditioning on the expression of total and phosphorylated isoforms of extracellular signal-regulated kinases (ERK)1/2 and AKT serine/threonine kinase (Akt) were determined in LV myocardial tissue samples following IR. There was no significant difference in the expression of phospho-ERK1/ Figure 1 : Experimental protocol. Control (control IR group, n = 10) and argon treatment (argon IR; n = 10) with 3 cycles of argon (50% argon, 21% oxygen and 29% nitrogen administered for 5 min, n = 10) interspersed with 5 min of gas (79% nitrogen and 21% oxygen) in vivo. Ex vivo protocol: Hearts were perfused for 15 min in the LD, followed by 20 min in the WH mode (WH-haemodynamic baseline value) prior to cardiac arrest for 60 min by HTK cardioplegia, followed by 40 min reperfusion with the LD and working heart modes. HTK: histidine-tryptophan-ketoglutarate; IR: ischaemia-reperfusion; LD: Langendorff mode; WH: working heart. Table 1 : Animal characteristics and baseline haemodynamic function using the working heart system ex vivo
Parameters
Sham (n = 4) Control IR (n = 10) Argon IR (n = 10) BW (g) 428 ± 31 426 ± 24 414 ± 23 HW (g)
1.70 ± 0.10 1.62 ± 0.09 1.52 ± 0.05 CO (ml/min/g heart) 51.3 ± 1.9 50.6 ± 1.6 51.2 ± 1.6 CF (ml/min/g heart) 3.1 ± 0.1 2.9 ± 0. Data are shown as mean ± standard deviation. BW: body weight; CF: coronary flow; CO: cardiac output; EHW: external heart work; HR: heart rate; HW: heart weight; IR: ischaemia-reperfusion; LVSP: left ventricular systolic pressure; SV: stroke volume.
2 and phospho-Akt normalized to total ERK1/2 and Akt between the 2 groups ( Fig. 3A and B) . However, there was a clear tendency of increased phospho-endothelial nitric oxide synthase (eNOS)/eNOS in LV tissue samples from the group preconditioned with argon compared to the control IR group, although the difference was not statistically significant (P = 0.067, Fig. 3C ).
Argon preconditioning, attenuated JNK activation and HGMB1 expression following global cold ischaemia and reperfusion
The activation of jun N-terminal kinase (JNK) was markedly attenuated in myocardial tissue samples following IR in rats that were preconditioned with argon compared to the control IR group (the expression of p-JNK/JNK; 0.11 ± 0.01 vs 0.25 ± 0.03; P = 0.005; Fig. 4A) . Similarly, the protein expression of high-mobility group box 1 (HMGB1) protein from the LV tissue samples was significantly decreased in rats treated with argon compared to the control IR rats (the expression of HGMB1/glyceraldehyde 3-phosphate dehydrogenase; 0.52 ± 0.04 vs 1.5 ± 0.10; P < 0.001; Fig. 4B ).
Argon preconditioning improves energy status in the myocardium
Phosphocreatine (PCr) levels, the buffering energy source for adenosine triphosphate (ATP) in situations of energy demand, were The effect of preconditioning with argon on the recovery of postischaemic cardiac function following histidine-tryptophan-ketoglutarate cardioplegia arrest and ischaemia. Recovery of (A) cardiac output, (B) stroke volume, (C) external heart work, (D) LV systolic pressure, (E) coronary flow and (F) heart rate during 40 min of reperfusion. Postischaemic haemodynamic functional parameters in the working heart mode were calculated as percent of baseline value. Data are shown as mean ± standard deviation from 10 animals from each group. Significant differences between groups are shown: *P < 0.05; ***P < 0.001. IR: ischaemia-reperfusion; LV: left ventricular.
significantly higher in animals with argon preconditioning (PCr: 23.71.11 ± 2.07 mmol/g protein vs the control IR group, 13.50 ± 4.75 mmol/g protein, P = 0.001) and were comparable to the levels in the sham group (Fig. 5A) . The ATP values of the group preconditioned with argon did not significantly differ from those of the sham group (13.62 ± 189 mmol/g protein vs 15.50 ± 0.51 mmol/g protein), whereas a significant decline in ATP values was observed in the control IR group vs the sham group (ATP: 10.08 ± 1.94 mmol/g protein vs 15.50 ± 0.51 mmol/g; P < 0.01). In addition, significantly higher ATP values were observed in the hearts preconditioned with argon compared to the hearts from the control IR group (ATP: 13.62 ± 1.89 mmol/g protein vs control IR group ATP: 10.08 ± 1.94 mmol/g; P = 0.017). The only significant difference in adenosine monophosphate content of the hearts occurred between the sham group and the control IR group (adenosine monophosphate: 1.53 ± 0.34 mmol/g protein vs control IR group, 3.23 ± 0.97 mmol/g protein; P = 0.021). The adenosine diphosphate values did not differ significantly between groups (Fig. 5A ). The energy charge (EC) was also higher in the hearts preconditioned with argon compared to the control IR group but did not reach statistical significance (EC = 0.76 ± 0.05 vs control IR group, EC = 0.68 ± 0.06). However, there was a significant decline in the EC in the control IR group compared to the sham group (EC = 0.68 ± 0.060 vs sham group EC = 0.82 ± 0.02, P = 0.004; Fig. 5B ). No significant difference in the EC of hearts was found between the sham and the argon preconditioned groups. 
DISCUSSION
Postischaemic cardiac dysfunction and the limited therapies available to eliminate myocardial damage in the setting of cardiopulmonary bypass (CPB) ultimately require novel approaches with significant cardioprotective efficacy. The present study is, to the best of our knowledge, the first to demonstrate that preconditioning with argon enhances postischaemic cardiac functional recovery and reduces myocardial injury in rat hearts arrested with HTK cardioplegia as well as subjected to global cold ischaemia and reperfusion. These effects are associated with the maintained levels of phosphocreatine and ATP following reperfusion as well as with the marked decline in mediators of apoptosis and inflammation, exemplified by activated JNK and HMGB1 protein levels, respectively. Additionally, preconditioning with argon significantly increases coronary flow in association with enhanced eNOS phosphorylation. Based on previous studies demonstrating the cardioprotective effects of argon in the setting of acute myocardial IR injury [11, 16] , we hypothesized that preconditioning with argon gas prior to HTK-induced cardioplegic arrest would attenuate IR injury and enhance postischaemic cardiac function. Accordingly, rats that were preconditioned with a gas mixture containing 50% argon exhibited significantly enhanced recovery of cardiac functional parameters during reperfusion. These results are in accordance with previous data demonstrating that postconditioning with argon (80%) improved the contractility of human atrial trabeculae in an in vitro model of hypoxia-reoxygenation injury. [12] The cardioprotective effect of argon pre-or postconditioning was blunted in the presence of wortmannin and PD98059, which inhibit Akt and ERK1/2 signalling pathways, respectively [11, 17] . In contrast, a recent study by Mayer et al. [16] demonstrated that argon preconditioning did not alter the phosphorylation status of ERK1/2 and Akt protein expression. Substantial evidence indicates that activation of the Akt-and the ERK1/2-mediated signalling pathways targets diverse cellular control functions, including protein synthesis, energy metabolism and cellular survival and protects against myocardial IR injury in the setting of acute myocardial infarction.
In the setting of CPB, the activation of the mitogen-activated protein kinase (MAPK) signalling pathway during the early stage of reperfusion, including the activation of ERK1/2 and JNK, is considered to be involved in the development of vascular and myocardial IR injury [18] . Interestingly, Araujo et al. [19] demonstrated an oscillatory pattern of the activation and the deactivation (late stage of reperfusion) of the ERK1/2 signalling pathway in a pig model of CPB. Moreover, human umbilical vein endothelial cells exposed to hypothermia and rewarming up-regulated ERK1/2 expression, leading to the release of pro-inflammatory cytokines [19] . In the present study, preconditioning with argon slightly reduced the activation of ERK1/2. Nevertheless, further studies are required to clarify the exact role of the activation or inactivation of the ERK1/2-mediated signalling pathways in relation to myocardial and endothelial function and dysfunction in the setting of CPB.
Both myocardial and endothelial damage with temporary cardiac dysfunction is a well-described phenomenon in CPB. Previous studies demonstrated the significance of endothelial function integrity in postischaemic functional recovery [20] . Of importance, preconditioning the hearts of rats with argon markedly enhanced the recovery of coronary flow, which was associated with an increase in the phosphorylation of eNOS protein expression. Moreover, Smit et al. [21] demonstrated that preconditioning with the noble gas helium protected against forearm IR injury in human subjects. These data indicate the potential beneficial effect of helium and argon on endothelial function.
The biological hallmark of myocardial IR injury following cardioplegic arrest is associated with the increase of apoptosis, which contributes to impaired cardiac functional recovery [22] . In addition, substantial evidence indicates that the activation of JNK and HGMB1 overexpression plays a mandatory role concerning apoptosis and inflammation in a setting of CPB, respectively [22, 23] . Of importance, we have found that preconditioning human adult cardiomyocytes with argon (30% and 50%) prior to exposure to hypoxia markedly reduced the expression of apoptosis and inflammatory cytokines [13] . In this study, apoptosis and inflammation were demonstrated by the activation of JNK and HMGB1 protein expression, respectively. Preconditioning with argon gas markedly decreased activation of JNK protein in the LV tissue samples. This finding was accompanied by an enhancement of myocardial and vascular recovery following reperfusion in hearts arrested with HTK cardioplegia and subjected to ischaemia. Recent studies demonstrated a deleterious inflammatory role of HMGB1, which is released from apoptotic, necrotic and activated immune cells during cardiac surgery [24] . The overexpression of HGMB1 initiates the activation of proinflammatory signalling pathways leading to the release of cytokines, such as tumour necrosis factor alpha, interleukin 6 and interleukin 1b [24] , that consequently contribute to impaired recovery of cardiovascular function and the development of the systemic inflammatory response syndrome following CPB. Our initial data showed that preconditioning with argon produced an antiinflammatory effect on rat hearts arrested with a crystalloid HTK cardioplegia solution.
Diminished reperfusion damage could also be demonstrated by the high-energy phosphate content of the left ventricle. We noted significant preservation of PCr levels and a minimal reduction in energy charge, crucial parameters reflecting the metabolic status of the organ preconditioned with argon. Mitochondrial creatine kinase is present in the mitochondrial intermembrane space and regenerates phosphocreatine from creatine imported from the cytosol and mitochondrial ATP. In the cytosol, phosphocreatine serves as an energy reservoir for the rapid buffering and regeneration of ATP in situ as well as for intracellular energy transport by the PCr shuttle or circuit [25, 26] . Thus, our findings indicate a decreased consumption of phosphocreatine in hearts preconditioned with argon. As a consequence of the high levels of PCr, the ATP levels were also significantly higher in hearts preconditioned with argon compared to the control IR group. In addition, the higher EC values, which did not differ from those of the sham group, also indicate better preservation of the hearts preconditioned with argon. In accordance with results from previous studies, high-energy phosphates, especially PCr, are maintained at high levels after ischaemia and reperfusion if a protective mechanism induced by argon preconditioning or a nitric oxide donor is involved. Reperfusion injury with a decline in the level of highenergy phosphates in untreated animals can be observed early (40-60 min) and is more pronounced after reperfusion for 2 h [27, 28] .
Finally, the clincal perspective of preconditioning with argon has to be stressed. Our increasingly older and multimorbid surgical population has different needs for myocardial protection than patients 20 years ago [29] . We recently proposed the concept of endothelial and myocardial protection, thereby improving the nitric oxide homeostasis following CPB [20] . Argon preconditioning can be performed easily by the anaesthaesiologist without interfering with the surgon's work and without prolonging the procedure. The current data indicate that it significantly improves recovery of postischaemic coronary flow and thereby has the potential to stabilize the patient in the most vulnerable phase during the operation. Additionally, the preserved high-energy phosphates guarantee optimal functional recovery during reperfusion and follow-up.
Limitations
As pointed out previously, no direct toxic effects of argon are known. To the best of our knowledge, there are no data on the adverse effects of argon in the setting of myocardial IR. However, certain limitations of the study need to be acknowledged. First, the data were obtained in an ex vivo isolated 'working' heart model, and it is not known whether similar results are valid for an in vivo model of CPB. Second, the efficacy of argon preconditioning on postischaemic cardiac functional recovery was demonstrated on rat hearts arrested with a crystalloid HTK cardioplegia solution. Thus, the effectiveness of the role of preconditioning with argon gas on blood cardioplegia solutions needs to be clarified in future studies. Third, there is substantial evidence that co-medications and comorbidities at least partially abolished the cardioprotective effect of preconditioning [30] . Therefore, further experimental studies are needed to clarify whether preconditioning with argon provides enhanced cardioprotection following cardioplegic arrest and ischaemia in patients with the above-mentioned conditions. Fourth, although the snapshot sampling at 10 min postreperfusion showed significant differences in the levels of LDH released between the groups, it does not reflect the peak levels of LDH release.
CONCLUSION
In conclusion, this study demonstrates a novel approach for the enhancement of postischaemic cardiac function by preconditioning rat hearts with argon following cardioplegic arrest and ischaemia. The beneficial effect of preconditioning with argon on the myocardium is accompanied with a marked reduction in JNK activation and expression of HMGB1 protein as well as in the levels of high-energy phosphates. Therefore, preconditioning with argon gas may offer a novel approach to reduce perioperative IR injury and enhance cardiac functional recovery in patients undergoing cardiac surgery.
